Thrivent Financial for Lutherans
ALT icon

Thrivent Financial for Lutherans’s Altimmune ALT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40,243
Closed -$569K – 2453
2021
Q1 		$569K Sell
40,243
-5,196
-11% -$84K ﹤0.01% 2182
2020
Q4 		$512K Buy
+45,439
New +$535K ﹤0.01% 2121

Other funds holding ALT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Thrivent Financial for Lutherans's ALT Position: Q2 2021 in Review

Thrivent Financial for Lutherans sold out of Altimmune (ALT) in Q2 2021, closing a stake of 40,243 shares — an estimated $569K sold.

Thrivent Financial for Lutherans first reported a position in ALT in Q4 2020 and held it in 2 quarters. The position peaked at $569K in Q1 2021. 109 funds tracked by Wall St. Rank hold ALT as of Q2 2021.

  • Thrivent Financial for Lutherans reported no remaining Altimmune position as of Q2 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 40,243 Altimmune shares in Q2 2021, an estimated $569K.
  • Thrivent Financial for Lutherans first reported a position in Altimmune in Q4 2020 and held it in 2 quarters.
  • Thrivent Financial for Lutherans's Altimmune position peaked at $569K in Q1 2021.
  • 109 funds tracked by Wall St. Rank held Altimmune as of Q2 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2021, filed 19 Aug 2021.